TY  - GEN
AU  - Vickers,M M
AU  - Powell,E D
AU  - Asmis,T R
AU  - Jonker,D J
AU  - Hilton,J F
AU  - O'Callaghan,C J
AU  - Tu,D
AU  - Parulekar,W
AU  - Moore,M J
TI  - Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo
SN  - 1879-0852
PY  - 2012///0823
KW  - Age Factors
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Comorbidity
KW  - Deoxycytidine
KW  - Erlotinib Hydrochloride
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Neoplasm Metastasis
KW  - Outcome Assessment, Health Care
KW  - Pancreatic Neoplasms
KW  - complications
KW  - Placebos
KW  - Proportional Hazards Models
KW  - Protein Kinase Inhibitors
KW  - Quinazolines
KW  - Risk
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ejca.2011.10.035
ER  -